Original language | English (US) |
---|---|
Journal | Clinical Gastroenterology and Hepatology |
DOIs | |
State | Accepted/In press - Jan 1 2018 |
Fingerprint
ASJC Scopus subject areas
- Hepatology
- Gastroenterology
Cite this
Advantages and Limitations of the Federal Adverse Events Reporting System in Assessing Adverse Event Reporting for Eluxadoline. / Chedid, Victor; Vijayvargiya, Priya; Camilleri, Michael.
In: Clinical Gastroenterology and Hepatology, 01.01.2018.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Advantages and Limitations of the Federal Adverse Events Reporting System in Assessing Adverse Event Reporting for Eluxadoline
AU - Chedid, Victor
AU - Vijayvargiya, Priya
AU - Camilleri, Michael
PY - 2018/1/1
Y1 - 2018/1/1
UR - http://www.scopus.com/inward/record.url?scp=85040763184&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85040763184&partnerID=8YFLogxK
U2 - 10.1016/j.cgh.2017.11.025
DO - 10.1016/j.cgh.2017.11.025
M3 - Article
C2 - 29155353
AN - SCOPUS:85040763184
JO - Clinical Gastroenterology and Hepatology
JF - Clinical Gastroenterology and Hepatology
SN - 1542-3565
ER -